The most important number in UK musculoskeletal care isn't a clinical trial result. It's the 12 weeks a patient with chronic back pain can wait for a first community physiotherapy appointment. For Finn Stevenson and Ric da Silva, the co-founders of Flok Health, that wait time is the wedge. Their company has built what they call the UK's first AI-powered physiotherapy clinic, a CQC-approved digital provider now delivering same-day video appointments for NHS patients with back pain [Maddyness, June 2024]. The bet is straightforward: replace a strained, human-only system with a hybrid pathway where an AI physiotherapist handles initial assessment and triage, freeing human clinicians for complex cases and follow-ups.
Flok's model is a regulated utility, not a consumer wellness app. The company went through the Care Quality Commission registration process in March 2023, a significant regulatory hurdle that allows it to operate as a licensed healthcare provider and deliver full treatment pathways directly to patients on behalf of NHS commissioners and Trusts [CQC, 2024]. This distinction is critical. It means Flok isn't selling a self-management tool to individuals; it's selling a contracted service to the NHS, automating a chunk of the clinical workload for a condition that accounts for roughly a third of all GP appointments [Maddyness, June 2024]. The early traction signal is the waiting list. In a 2023 trial with Cambridge University Hospitals, the health system reported that waiting lists for in-person appointments increased by more than 50% during periods when the AI clinic was not in use [IT Brief UK, 2024].
The Regulatory Wedge
Securing CQC approval as a digital MSK provider is Flok's primary competitive moat. In the crowded field of digital physiotherapy and musculoskeletal apps, most offerings are classified as wellness or low-risk medical devices. Flok's Class IIa medical device clearance under EU regulations and its CQC registration position it uniquely to operate inside formal NHS care pathways [IT Brief UK, 2024]. This allows the company to be commissioned directly, with NHS partners effectively outsourcing a portion of their MSK service delivery. The company has expanded this model to 11 NHS areas, suggesting a repeatable, if early, sales motion into regional integrated care systems [IT Brief UK, 2024]. For a cash-strapped NHS, the value proposition is operational efficiency. Flok claims its service more than halves back pain waiting lists, and in one reported pilot, 86% of patients said their symptoms improved during treatment [Integrated Care Journal, 2024] [East Region Innovation, 2024].
An Uncommon Funding Profile
What is notable, from a commercial lens, is what hasn't happened. Despite operating since 2022 and securing major regulatory approvals in 2023, Flok Health has not publicly disclosed any venture funding rounds. The company's path appears bootstrapped or grant-funded, a rarity for a healthtech startup tackling a massive NHS pain point. This suggests a capital-efficient, perhaps service-revenue-led, approach to scaling. The current public team footprint is lean, centered on the two co-founders. Stevenson acts as CEO, while da Silva is the CTO [MedTech Pulse, 2026] [The Org, 2024]. Their public hiring appears focused on clinical capacity, with an open role for a Senior MSK Physiotherapist, indicating a build-out of the human side of their hybrid model.
| Role | Name | Notes |
|---|---|---|
| CEO & Co-founder | Finn Stevenson | Leading commercial and clinical strategy [MedTech Pulse, 2026]. |
| CTO & Co-founder | Ric da Silva | Leading technical development since March 2022 [The Org, 2024]. |
The Risks in the Pathway
The company's early success is inextricably linked to the NHS, which presents both its greatest opportunity and its most significant risk. Flok's entire business model is built on selling to a single, monolithic customer with famously long procurement cycles and budgetary uncertainty. While the NHS's digital transformation push is a powerful tailwind, it is also a political football. A change in commissioning priorities or a shift in central funding could stall growth overnight. Furthermore, the clinical AI itself operates in a high-stakes, low-margin environment. The model's performance and patient safety are paramount; any significant clinical error or data privacy incident could unravel hard-won trust with commissioners and trigger regulatory re-evaluation.
Flok also enters a market with established, if different, competitors. Companies like Phio by EQL.ai and Motics offer digital MSK solutions, though often with a different regulatory stance or go-to-market focus. The competitive landscape hinges on three factors:
- Regulatory gate. Flok's CQC provider status is a significant barrier to entry for pure software companies.
- Clinical integration. The ability to slot into existing NHS IT and referral workflows is non-negotiable.
- Outcome proof. Long-term data on patient recovery rates and cost savings per pathway will ultimately determine contract renewals and expansion.
For patients with chronic lower back pain, the current standard of care is a frustrating cycle of GP visits, pain medication, and a long wait for specialist assessment. That first physiotherapy appointment, often weeks or months away, is merely the starting gate for a rehabilitation journey that requires consistent, guided exercise. Flok's intervention aims to collapse that initial delay to zero, providing immediate access to structured care. The ambition is to show that for common, high-volume MSK conditions, an AI-augmented pathway can deliver equivalent or better outcomes than the traditional model, while freeing scarce human clinicians for the cases that truly need them. The next twelve months will test whether that proof can scale from 11 NHS areas to dozens more, turning a promising pilot into a new standard for musculoskeletal care in the UK.
Sources
- [Maddyness, June 2024] Flok Health, a fusion of AI and human physios for world-class care | https://www.maddyness.com/uk/2024/06/15/flok-health-a-fusion-of-ai-and-human-physios-for-world-class-care/
- [Care Quality Commission, 2024] Flok Health - Care Quality Commission | https://www.cqc.org.uk/location/1-15266686452
- [IT Brief UK, 2024] Flok Health expands digital physio to 11 NHS areas | https://itbrief.co.uk/story/flok-health-expands-digital-physio-to-11-nhs-areas
- [Integrated Care Journal, 2024] UK's first AI-powered physio more than halves back pain waiting lists | https://integratedcarejournal.com/uks-first-ai-powered-physio-more-than-halves-back-pain-waiting-lists/
- [East Region Innovation, 2024] UK’s first AI physio clinic trialled by NHS to tackle wait times | https://hises.edinburghbioquarter.com/uks-first-ai-physio-clinic-trialled-by-nhs-to-tackle-wait-times/
- [MedTech Pulse, 2026] Flok Health Company Profile | https://medtechpulse.com/company/flok-health
- [The Org, 2024] Ric da Silva - Co-founder & CTO at Flok Health | https://theorg.com/org/flok-health/org-chart/ric-da-silva